Amylyx Pharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Amylyx Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2020 to Q4 2023.
  • Amylyx Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $2.21M, a 118% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $2.21M +$1.2M +118% Dec 31, 2023 10-K 2024-02-22
Q4 2022 $1.01M +$449K +79.6% Dec 31, 2022 10-K 2024-02-22
Q4 2021 $564K +$215K +61.6% Dec 31, 2021 10-K 2024-02-22
Q4 2020 $349K Dec 31, 2020 10-K 2024-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.